Candid-V6

White, double-branded tablets without a shell, oval shape, truncated on the one hand, with the monogram "G" on one side and the sign "V6" on the other.

Genital infections caused by yeast mushrooms of the genus Candida and / or Trichomonas vaginalis (candidosis vulvovaginitis, trichomoniasis); genital superinfectures caused by bacteria sensitive to clotrimazole (mixed vaginal infections, bacterial vaginitis).

Locally. Introduced intravaginally, deeply, in the position "lying on the back" with slightly bent legs. 1 tablet each. (100 mg) 1 time per day (in the evening) for 6 days. A repeated course of treatment is possible after consultation with a doctor.

Rarely - a feeling of slight burning immediately after the introduction of the pill, which takes place with continued treatment.

Acute overdose of local use of Abzorb is unlikely and does not lead to a life-threatening situation.

Hypersensitivity reactions to clotrimazole.

Dermatophytes, yeast mushrooms (birth) are sensitive to clotrimazole Candida, Torulopsis glabrata, kind Rhodotorula), mold mushrooms, as well as a pathogen Pityriasis versicolor (varietal lichen) and the causative agent of eritrazma.

In addition, it has an antimicrobial effect in relation to gram-positive (staphylococci and streptococcus) and gram-negative bacteria (Bacteroides, Gardnerella vaginalis)as well as in relation Trichomonas vaginalis, Malassezia furfur, Corynebacterium minimum.

Resorption is 3–10% of the entered dose.

• Anti-fungry agent [Fungry]

With vaginal administration, it reduces the activity of amphotericin B and other polyene antibiotics.

With simultaneous use with nistine, the activity of Candidate-B6 may decrease.

Keep out of the reach of children.

Do not apply after the expiration date indicated on the package.

in the contour unlabeled packaging 6 pcs.complete with applicator; in box 1 set.

In clinical and experimental studies, it was not found that the use of Candida-B6 during pregnancy and during breastfeeding negatively affects the health of a woman or fetus. However, the question of the appointment of the drug should be decided individually by the doctor. In this case, the use of the applicator is not recommended.

To prevent urogenital refraction, simultaneous treatment of both sexual partners is necessary.

In trichomoniasis, other drugs with systemic effects, such as metronidazole, should be prescribed for more successful treatment, together with Candid-B6.

Vaginal tablets are not recommended to be used during menstruation.

• A59.0 Urogenital trichomoniasis
• B37.3 Vulva and vagina candidiasis (N77.1 *)
• N76 Other inflammatory diseases of the vagina and vulva